Nanoparticle-based modulation of the immune system

Summary

This review surveys how engineered nanoparticles are being used to alter immune responses across disease prevention and treatment. Because immunity contributes to nearly every disease process, nanomaterials can be designed either to stimulate protective responses, suppress harmful inflammation, or supplement endogenous immune functions. The authors organize major application areas and highlight recent advances enabled by increasingly precise control over particle size, composition, surface chemistry, cargo, and delivery behavior. The central conclusion is that nanoscale engineering offers a flexible way to present immunological signals in selected combinations and locations, potentially improving existing immunomodulatory approaches and opening new ones. Its significance lies in matching a material's design to a desired immune outcome rather than treating nanoparticles only as passive drug containers. The abstract, however, provides a high-level field overview rather than new experimental results or a systematic evaluation. It does not specify which immune pathways, diseases, or platforms have the strongest evidence, nor does it compare efficacy and risk quantitatively. Immune responses can vary by dose, route, disease state, and patient, but these sources of heterogeneity are not addressed. Long-term immune consequences, off-target inflammation or suppression, biodistribution, manufacturing consistency, and clinical translation remain unresolved.